Table 1 Comparison of the baseline demographics between 2001–2005 and 2006–2010 in patients with pancreatic cancer (n = 1,082)
Total | 2001–2005 | 2006–2010 | P-value | ||
|---|---|---|---|---|---|
Age (y) | 71.5 ± 10.9 | 71.0 ± 10.4 | 71.8 ± 11.2 | 0.24911 | |
Sex (Male/Female) | 566/516 | 210/196 | 356/320 | 0.76472 | |
Stage | I | 22 (2.0%) | 10 (2.5%) | 12 (1.8%) | 0.43762 |
II | 37 (3.4%) | 13 (3.2%) | 24 (3.6%) | 0.76022 | |
III | 141 (13.0%) | 46 (11.3%) | 95 (14.0%) | 0.19762 | |
IVa | 288 (26.6%) | 113 (27.8%) | 175 (25.9%) | 0.48342 | |
IVb | 594 (54.9%) | 224 (55.2%) | 370 (54.7%) | 0.88832 | |
Treatment | Surgery | 187 (17.3%) | 64 (15.8%) | 123 (18.2%) | 0.30572 |
Chemotherapy | 519 (48.0%) | 172 (42.4%) | 347 (51.3%) | <0.00012 | |
BSC/RT | 376 (34.8%) | 170 (41.9%) | 206 (30.5%) | 0.00042 | |
Cause of death | 654/31 | 274/12 | 380/19 | 0.72522 | |
PC related/PC unrelated | |||||